Disproportionality analysis of acetaminophen-induced hepatic disorders with and without immune checkpoint inhibitors-Reference-Cited by-同舟云学术

Disproportionality analysis of acetaminophen-induced hepatic disorders with and without immune checkpoint inhibitors

Published:2023-01-06 Issue:2 Volume:45 Page:442-450
ISSN:2210-7703
Container-title:International Journal of Clinical Pharmacy
language:en
Short-container-title:Int J Clin Pharm

Author:

Yamada Tomoyuki^ORCID,Kato Ryuji,Ijiri Yoshio,Nishihara Masami,Neo Masashi

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy

Link

https://link.springer.com/content/pdf/10.1007/s11096-022-01527-z.pdf

Reference25 articles.

1. Aminoshariae A, Khan A. Acetaminophen: old drug, new issues. J Endod. 2015;41:588–93. https://doi.org/10.1016/j.joen.2015.01.024.

2. WHO. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. https://www.who.int/publications/i/item/9789241550390. Accessed 01 Jan 2022.

3. Ishitsuka Y, Kondo Y, Kadowaki D. Toxicological property of acetaminophen: the dark side of a safe antipyretic/analgesic drug? Biol Pharm Bull. 2020;43:195–206. https://doi.org/10.1248/bpb.b19-00722.

4. Ramachandran A, Jaeschke H. Acetaminophen hepatotoxicity. Semin Liver Dis. 2019;39:221–34. https://doi.org/10.1055/s-0039-1679919.

5. Yan M, Huo Y, Yin S, et al. Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions. Redox Biol. 2018;17:274–83. https://doi.org/10.1016/j.redox.2018.04.019.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative safety profile of bivalent and original COVID-19 mRNA vaccines regarding myocarditis/pericarditis: A pharmacovigilance study;International Immunopharmacology;2024-05